REQUEST A DEMO
Total
USD $0.00
Search more companies

Voma Ecza Deposu Medikal Urunler A.S. (Turkiye)

Main Activities: Medical, Dental, and Hospital Equipment and Supplies Merchant Wholesalers
Full name: Voma Ecza Deposu Medikal Urunler Sanayi Ve Ticaret Anonim Sirketi Profile Updated: May 30, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2022 Available in: English Download a sample report

Voma Pharmaceuticals & Medical Devices is a Turkish wholesaler supplying pharmaceutical and medical device products from international brands to partners in Turkey and abroad. They have a sales team and have gained experience in the healthcare industry, with a trade volume of 6.5 million USD by the end of 2017. They are participating in the Arab Health 2019 exhibition and have obtained an international pharmaceutical trade license.

Headquarters
A Blok Sitesi A Blok Apartmani No:26-2 Fatih Mahallesi 1191 Sokak Gaziemir
Izmir; Aegean; Postal Code: 35410

Contact Details: Purchase the Voma Ecza Deposu Medikal Urunler A.S. report to view the information.

Website: http://www.voma.com.tr

Basic Information
Total Employees:
Purchase the Voma Ecza Deposu Medikal Urunler A.S. report to view the information.
Outstanding Shares:
Purchase the Voma Ecza Deposu Medikal Urunler A.S. report to view the information.
Incorporation Date:
March 02, 2010
Key Executives
Purchase this report to view the information.
Chairman
Company Performance
Financial values in the chart are available after Voma Ecza Deposu Medikal Urunler A.S. report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency TRY. Absolute financial data is included in the purchased report.
Net sales revenue
91.13%
Total operating revenue
91.13%
Operating profit (EBIT)
139.33%
Net Profit (Loss) for the Period
206.05%
Total assets
119.89%
Total equity
152.19%
Operating Profit Margin (ROS)
5.29%
Net Profit Margin
8.32%
Return on Equity (ROE)
10.62%
Debt to Equity Ratio
-8.53%
Quick Ratio
2.29%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?